Replies to post #249388 on Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

"Five months latter and no clarification extremely disappointing and very poor budgeting from a cpa, not a leo basher but facts speak for themselves.
That p/r led most to believe results would be announced soon. Start of the summer slaughter that has yet to be reversed."

Yeah, I think most have relinguished faith in "the" CEO's words.

Polly want a cracker?

Maura Healey can be a pit bull.

[MinnieM]

The Challenge Of Vendor Selection, Cost Overruns, And Change Orders
https://www.clinicalleader.com/doc/the-challenge-of-vendor-selection-cost-overruns-and-change-orders-0001

The last section on change orders and cost overruns is interesting.

[frrol]

He did run the balance sheet thin, in the expectation of timely P results and a B deal. The pay off would have been no dilution. That was a risk that didn't pay off obviously. He's hustling now. I've got my fingers crossed on that B deal. B-OM BTD now unlikely.